CanSino: vaccine talks with EU countries

The Chinese pharmaceutical manufacturer CanSino Biologics announced it would hold talks with several EU countries about a possible order for its Covid-19 vaccine. Three European Union member states had approached the Tianjin-based vaccine developer to discuss a possible purchase, Pierre Morgon, CanSino’s Senior Vice President in charge of international business, confirmed to China.Table. Morgon would not disclose which EU countries were involved, citing ongoing talks.